Figure 2.
Cumulative overall survival rates and Kaplan–Meier analysis of between TACE plus sorafenib and TACE alone groups (Log-Rank P < 0.001). TACE: Transarterial chemoembolization
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.